Effects of Oseltamivir Phosphate (Tamiflu) and Its Metabolite (GS4071) on Monoamine Neurotransmission in the Rat Brain
Authors:
Open Access
- 1 January 2007
- journal article
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 30 (9) , 1816-1818
Abstract
As abnormal behaviors such as jumping and falling from balcony were reported in patients aged 10 to 19 years who administrated oseltamivir phosphate (Tamiflu) for treatment influenza infection, the Ministry of Health, Labor and Welfare in Japan notified that, as a rule, Tamiflu should not be prescribed to patients aged 10 to 19 years. To examine the relationship between Tamiflu and abnormal behaviors, we investigated the effects of Tamiflu and its carboxylic acid metabolite, GS4071, on the central nervous system, that is, on 3 neurotransmitters (dopamine, serotonin, and norepinephrine) in presynapses (inhibition of re-uptake, promotion of release) and postsynapses (guanosine 5′-triphosphate (GTP) γS binding), using rat brain synaptosomes. Neither Tamiflu nor GS4071 influenced the re-uptake/release of the 3 monoamines or GTP binding in postsynapses.Keywords
This publication has 11 references indexed in Scilit:
- The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brainEuropean Journal of Pharmacology, 2007
- Second Generation Catalytic Asymmetric Synthesis of Tamiflu: Allylic Substitution RouteOrganic Letters, 2006
- De Novo Synthesis of Tamiflu via a Catalytic Asymmetric Ring-Opening of meso-Aziridines with TMSN3Journal of the American Chemical Society, 2006
- Effects of N-nitrosofenfluramine, a component of Chinese dietary supplement for weight loss, on CD-1 miceArchives of Toxicology, 2006
- Influenza-Associated Deaths among Children in the United States, 2003–2004New England Journal of Medicine, 2005
- Experience with Oseltamivir for Infants Younger Than 1 Year Old in JapanThe Pediatric Infectious Disease Journal, 2005
- Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoidsNeuropharmacology, 2004
- Safety and Pharmacology of Oseltamivir in Clinical UseDrug Safety, 2003
- Agonist-stimulated [35S]GTPγS binding in brainNeuropharmacology, 2000
- Penetration of GS4071, a novel influenza neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104Antimicrobial Agents and Chemotherapy, 1997